We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 9,555

Six Chinese PVC manufacturers fined by the NDRC for price fixing
  • Slaughter and May
  • China
  • September 20 2017

Six Chinese polyvinyl chloride (PVC) manufacturers have been fined by the National Development and Reform Commission (NDRC) for price fixing in the


Fifth Circuit Rules In Favor Of Pharmaceutical Manufacturer Based on Relators’ Failure to Establish Causation
  • Sidley Austin LLP
  • USA
  • September 20 2017

Last week, the Fifth Circuit affirmed summary judgment for Solvay Pharmaceuticals Inc. on allegations that the company violated the False Claims Act


UK Publishes Draft Legislation Prohibiting the Manufacture and Supply of Cosmetic Products Containing Microbeads
  • Hogan Lovells
  • Global, United Kingdom
  • September 19 2017

On 11 September 2017, the UK Department for Environment, Food and Rural Affairs (DEFRA) published draft regulations prohibiting the manufacture and


Auto 2.0 Is More Than Just About the Automobile - From Shuttles to Logistics and More
  • Foley & Lardner LLP
  • USA
  • September 18 2017

The introduction of near autonomous vehicles to public roadways is set to completely revolutionize the way humans and goods navigate cityscapes in the


OIG Releases September Work Plan Items; Includes Part D Sponsor Reporting of Rebates and Price Concessions to Medicare
  • Cooley LLP
  • USA
  • September 18 2017

As we recently announced, the Office of Inspector General (OIG) is updating its Work Plan monthly rather than its previous twice-yearly publications


California Governor Considers Drug Price Reporting Bill and Ban on Discounts and Rebates for Branded Pharmaceutical Products
  • Cooley LLP
  • USA
  • September 18 2017

The California State Legislature sent two new pharmaceutical pricing measures, S.B. 17 and A.B. 265, to Governor Jerry Brown on September 13th. S.B


The life sciences industry under the antitrust spotlight in China: two practical points
  • Hogan Lovells
  • China
  • September 15 2017

The simple fact is that the Chinese antitrust regulators are determined to up their enforcement activities in the life sciences industry. Almost


Ministry of Labour Orders to Pay: Ignore at your own risk
  • Rubin Thomlinson LLP
  • Canada
  • September 15 2017

On August 21, 2017, the Ministry of Labour ("MOL") issued a $49,000.00 fine against an employer that failed to comply with Orders to Pay. The


Northern District of New York (Quickly!) Holds that the MDA Expressly Preempts Essure Suit
  • Reed Smith LLP
  • USA
  • September 14 2017

A couple of weeks ago, our co-blogger, Mr. McConnell, published a post on the benefits of brevity. That post sprang from an argument before the JPML


FDA Clarifies Trading Partners Under the DSCSA
  • Reed Smith LLP
  • USA
  • September 14 2017

The Federal Food and Drug Administration ("FDA") recently published a draft guidance to assist industry and State and local governments in